# IRulya Therapeutics Inc.: Form 8-K, filed Sep 26, 2025

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2025-09-26
- Accepted by EDGAR: Sep 26, 2025, 16:45 ET
- Period: 2025-09-25
- Accession: 0001193125-25-220722
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312525220722/d911581d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312525220722/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312525220722/d911581d8k.htm

Filed Sep 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-220722. Last ingested by Listed: Nov 15, 2026, 02:27 ET. No prices; not investment advice.
